Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosis

DCBs were associated with lower rates of the primary end point all-cause death or myocardial infarction, as well as secondary end points all-cause death and bleeding compared with second-generation DES. These findings suggest that DCBs may represent a safe and effective alternative to DES in selected patient populations.

Authors

Institutions

Publication Details

Journal
Clinical Research in Cardiology
Published
2025-11-25
DOI
https://doi.org/10.1007/s00392-025-02781-7
Citations
2
Primary Topic
Coronary Interventions and Diagnostics
Type
article
Field-Weighted Citation Impact
4.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosis

Heribert Schunkert, Hendrik B. Sager, Johannes Krefting, Thorsten Kessler et al.
2 citations
Clinical Research in Cardiology
Coronary Interventions and Diagnostics
4.01
article

Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosis

Heribert Schunkert, Hendrik B. Sager, Johannes Krefting, Thorsten Kessler, Adnan Kastrati, Fabian Starnecker, Sebastian Kufner, Tobias Dreischulte, Teresa Trenkwalder, Matthias Schwab, Jens Wiebe, Roberta Schmieder, Christian Gräßer, Daniele Giacoppo, Salvatore Cassese, Erion Xhepa, Felix Voll, Moritz von Scheidt, N. Krüger, Frank Offenborn, Christian Frieß
article en
2 citations

Abstract

DCBs were associated with lower rates of the primary end point all-cause death or myocardial infarction, as well as secondary end points all-cause death and bleeding compared with second-generation DES. These findings suggest that DCBs may represent a safe and effective alternative to DES in selected patient populations.

Clinical Research in CardiologyVol. 115(1)
LMU Klinikum (DE), AOK (DE), German Centre for Cardiovascular Research (DE), Deutsches Herzzentrum München (DE), Technical University of Munich (DE), Bayer (Germany) (DE), Ludwig-Maximilians-Universität München (DE)
Openalex Percentile: Top 6%
Coronary Interventions and Diagnostics
4.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.